Skip to main content
Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
378.95
+2.34 (0.62%)
Aug 13, 2025, 4:00 PM - Market closed

Stryker Revenue by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Medsurg and Neurotechnology
14.39B 13.73B 13.22B 12.77B 12.40B 12.15B 11.84B 11.46B - - - - - - - - - - - - - - - - - - -
Medsurg and Neurotechnology Growth
16.01% 13.08% 11.71% 11.40% 10.84% 11.65% 11.54% 12.36% - - - - - - - - - - - - - - - - - - -
Orthopedics and Spine
9.43B 9.48B 9.37B 9.21B 8.99B 8.82B 8.66B 8.43B - - - - - - - - - - - - - - - - - - -
Orthopedics and Spine Growth
4.93% 7.55% 8.21% 9.28% 8.72% 9.21% 10.51% 8.72% - - - - - - - - - - - - - - - - - - -
Medsurg
- - - - - - - - - - - - - - - 6.98B 6.82B 6.40B 6.40B 6.38B 6.36B 6.65B 6.57B
Medsurg Growth
- - - - - - - - - - - - - - - 9.32% 7.30% -3.80% -2.65% -1.15% 0.55% 7.95% 8.75%
Orthopedics
- - - - - - - - - - - - - - - 6.17B 5.96B 5.22B 4.96B 4.90B 4.85B 5.22B 5.25B
Orthopedics Growth
- - - - - - - - - - - - - - - 25.86% 22.91% -0.06% -5.58% -5.06% -4.44% 3.96% 5.23%
Neurotechnology
- - - - - - - - - - - - - - - 3.52B 3.47B 3.10B 2.99B 2.94B 2.87B 3.08B 3.06B
Neurotechnology Growth
- - - - - - - - - - - - - - - 19.99% 21.00% 0.52% -2.16% 0.20% 1.99% 14.54% 19.22%

Medsurg and Neurotechnology Revenue Breakdown
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Medical
4.02B 3.93B 3.85B 3.75B 3.61B 3.55B 3.46B 3.35B
Medical Growth
11.16% 10.94% 11.36% 11.90% 8.80% 12.72% 14.12% 19.58%
Endoscopy
3.61B 3.48B 3.39B 3.28B 3.18B 3.11B 3.03B 2.84B
Endoscopy Growth
13.63% 11.73% 11.74% 15.48% 18.15% 20.52% 25.18% 20.32%
Instruments
2.97B 2.90B 2.83B 2.78B 2.73B 2.66B 2.57B 2.49B
Instruments Growth
8.72% 8.87% 10.32% 11.83% 14.04% 14.40% 12.72% 11.68%
Neuro Cranial
2.22B 2.02B 1.84B 1.67B 1.62B 1.57B 1.55B 1.50B
Neuro Cranial Growth
37.48% 28.53% 18.79% 11.90% 11.98% 11.79% 12.57% 13.68%
Neurovascular
1.57B 1.40B 1.31B 1.29B 1.27B 1.25B 1.23B 1.21B
Neurovascular Growth
24.13% 12.06% 6.61% 6.72% 6.73% 5.83% 2.17% 0.08%
Other
- - - - - - - - - - 302.00M 292.00M

Orthopedics and Spine Revenue Breakdown
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Trauma and Extremities
3.75B 3.62B 3.51B 3.37B 3.27B 3.21B 3.15B 3.06B
Trauma and Extremities Growth
14.45% 12.91% 11.44% 10.13% 9.83% 10.97% 12.11% 11.55%
Knees
2.54B 2.50B 2.45B 2.39B 2.34B 2.30B 2.27B 2.20B
Knees Growth
8.61% 8.85% 7.66% 8.88% 8.05% 9.34% 13.82% 11.53%
Hips
1.79B 1.75B 1.70B 1.66B 1.60B 1.56B 1.54B 1.51B
Hips Growth
12.21% 12.29% 10.36% 9.97% 7.18% 6.91% 9.27% 8.27%
Spine
- 963.00M 1.10B 1.23B 1.22B 1.21B 1.19B 1.17B 1.16B
Spine Growth
- -20.08% -7.74% 5.22% 5.10% 4.69% 3.75% 1.65% -
Other
694.00M 647.00M 618.00M 562.00M 565.00M 548.00M 509.00M 496.00M
Other Growth
22.83% 18.07% 21.41% 13.31% 18.45% 16.10% 7.16% -0.40%

Revenue by Geography
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
United States
17.98B 17.47B 16.94B 16.43B 16.00B 15.66B 15.26B 14.76B
United States Growth
12.39% 11.56% 11.05% 11.26% 10.73% 11.49% 11.87% 11.89%
International
5.84B 5.75B 5.65B 5.55B 5.39B 5.30B 5.24B 5.12B
International Growth
8.31% 8.39% 7.84% 8.32% 7.66% 8.09% 8.94% 7.74%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.